Browsing Tag
J.P. Morgan
36 posts
Rio Tinto (NYSE, LSE, ASX: RIO) faces Oyu Tolgoi reset demand as Mongolia cites 11% loan rate and disappearing dividends
Mongolia demands Rio Tinto slash Oyu Tolgoi loan rates and fees as copper prices hit records. Read what's at stake for investors and the broader mining sector.
Warner Bros. Discovery confirms new tender offer from Paramount Skydance but maintains support for Netflix merger
Warner Bros. Discovery weighs a new offer from Paramount Skydance but holds firm on its Netflix merger. Find out why the board still says no.
MGT becomes America’s first SLED unicorn after $350m Ares Management investment
Find out how MGT’s $350 million investment from Ares Management is changing the SLED services industry—read the full story behind America’s newest unicorn.
Why IonQ’s massive $2bn equity raise could redefine the future of quantum computing
IonQ raises $2 billion to scale global quantum operations and accelerate commercialization—see how this move could reshape the industry.
Nova Compression secures $325mn in capital to accelerate mixed fleet expansion with backing from OIC and J.P. Morgan
Nova Compression raises $325M from OIC and J.P. Morgan to expand natural gas and electric fleets and pursue acquisitions; find out what this means now.
Can Neptune Insurance’s $2.76bn IPO withstand climate risk volatility?
Neptune Insurance seeks a $2.76B IPO valuation with AI-driven flood coverage. Discover what this means for climate risk, investors, and Wall Street momentum.
TP ICAP acquires Neptune Networks and launches new dealer-to-client credit platform
TP ICAP’s acquisition of Neptune and D2C credit venture with top banks aims to transform bond market liquidity and electronification. Learn how this reshapes fixed income trading.
e.l.f. Beauty to acquire Hailey Bieber’s rhode for $1bn in strategic prestige skincare push
e.l.f. Beauty is acquiring Hailey Bieber’s rhode for $1B to expand into prestige skincare. Explore the strategy, market impact, and what’s next.
Merck KGaA to acquire SpringWorks Therapeutics in $3.9bn rare tumor expansion
Find out how Merck KGaA, Darmstadt, Germany’s $3.9 billion SpringWorks acquisition is reshaping rare tumor treatment and global healthcare leadership.
SolarWinds goes private in $4.4bn deal as Turn/River bets big on AI-powered IT resilience
Turn/River acquires SolarWinds in a $4.4B deal, taking it private to boost observability, AI-driven IT tools, and hybrid cloud innovation—read more.